These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2237841)

  • 1. Thrombin activity in pulmonary emboli obtained at autopsy.
    Farstad IN; Nielsen DW; Ruyter R; Godal HC
    Thromb Res; 1990 Sep; 59(5):879-82. PubMed ID: 2237841
    [No Abstract]   [Full Text] [Related]  

  • 2. On the kinetics of the thrombin-controlled polymerization of fibrin.
    Visser A; Payens TA
    FEBS Lett; 1982 Jun; 142(1):35-8. PubMed ID: 7106285
    [No Abstract]   [Full Text] [Related]  

  • 3. Indices of fibrinogen proteolysis and platelet activation during the resolution of pulmonary embolism.
    Yudelman I
    Thromb Haemost; 1987 Feb; 57(1):11-6. PubMed ID: 2954258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the measurement of circulating fibrinogen derivatives.
    Wilner GD
    Prog Clin Pathol; 1984; 9():15-45. PubMed ID: 6229812
    [No Abstract]   [Full Text] [Related]  

  • 5. Radioimmunoassays of human fibrinopeptides A and B.
    Budzyński AZ; Marder VJ
    Pol Arch Med Wewn; 1978 Jan; 59(1):43-8. PubMed ID: 349523
    [No Abstract]   [Full Text] [Related]  

  • 6. Displacement of fibrin-bound thrombin by r-hirudin precludes the use of 131I-r-hirudin for detecting pulmonary emboli in the rabbit.
    Rubens FD; Ross-Ouellet B; Dennie C; Coates G; Kinlough-Rathbone RL; Hatton MW
    Thromb Haemost; 1994 Aug; 72(2):232-8. PubMed ID: 7831658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of thrombin-antithrombin complex (TAT) levels and fibrinopeptide A following thrombin incubation of human plasma using hirudin as an inhibitor of TAT formation.
    Haaland AK; Skjønsberg OH; Gravem K; Ruyter R; Godal HC
    Thromb Res; 1991 Feb; 61(3):253-9. PubMed ID: 2028444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinopeptide A release by factor-IX concentrates and FEIBA fraction (factor eight inhibitor bypassing activity).
    Hofmann V; Straub PW
    Thromb Res; 1980 Dec 1-15; 20(5-6):623-31. PubMed ID: 6785894
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinopeptide A in the diagnosis and treatment of deep venous thrombosis and pulmonary embolism.
    Joist JH
    Clin Lab Med; 1984 Jun; 4(2):363-80. PubMed ID: 6499399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
    Nossel HL; Ti M; Kaplan KL; Spanondis K; Soland T; Butler VP
    J Clin Invest; 1976 Nov; 58(5):1136-44. PubMed ID: 993337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of thrombin activity by immunoquantitation of fibrinopeptide A generation.
    Emanuele RM; Fareed J; Walenga JM; Hoppensteadt D; Fenton JW
    Semin Thromb Hemost; 1986 Oct; 12(4):318-23. PubMed ID: 3787269
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed thrombin generation is not associated with fibrinopeptide formation during prolonged cardiopulmonary bypass with hirudin anticoagulation.
    Belway D; Rubens FD; Henley B; Babaev A; Mesana T
    Perfusion; 2006 Dec; 21(5):259-62. PubMed ID: 17201079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin].
    Blanke H; Praetorius G; Leschke M; Seitz R; Egbring R; Strauer BE
    Klin Wochenschr; 1987 Aug; 65(16):757-63. PubMed ID: 2958657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
    Rooney MM; Mullin JL; Lord ST
    Biochemistry; 1998 Sep; 37(39):13704-9. PubMed ID: 9753458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen Sapporo: dysfibrinogenemia characterized by the replacement of A alpha arginine-16 by histidine resulting in the delayed release of fibrinopeptide A by thrombin.
    Asakura S; Terukina S; Yamazumi K; Matsuda M; Murayama H; Higuchi A; Musashi M; Sakurada K; Miyazaki T
    Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1094-104. PubMed ID: 2588959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrinogen Zürich I: defective fibrinopeptide-A release].
    Hofmann V; Gati WP; Straub PW
    Schweiz Med Wochenschr; 1977 Oct; 107(41):1468. PubMed ID: 918602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A thrombin assay based upon the release of fibrinopeptide A from fibrinogen: definition of a new thrombin unit.
    Lewis SD; Shafer JA
    Thromb Res; 1984 Jul; 35(2):111-20. PubMed ID: 6474412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin activity and oral anticoagulant therapy: a further evaluation.
    Marongiu F; Sorano GG; Mameli G; Mamusa AM; Cambuli AB; Conti M; Cadoni MC; Balestrieri A
    Haemostasis; 1990; 20(1):63-4. PubMed ID: 2323681
    [No Abstract]   [Full Text] [Related]  

  • 19. Biosynthesis of canine fibrinogen: in vitro synthesis of A alpha, B beta and gamma precursor chains.
    Yu S; Redman CM; Goldstein J; Blombäck B
    Biochem Biophys Res Commun; 1980 Oct; 96(3):1032-8. PubMed ID: 7437057
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of thrombin and fibrinogen and the polymerization of fibrin monomer.
    Scheraga HA
    Ann N Y Acad Sci; 1983 Jun; 408():330-43. PubMed ID: 6575693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.